Blood Cancer Journal - Table of Contents alert Volume 5 February 2015

TABLE OF CONTENTS Volume 5, February 2015 In this issue Review Original Article Letters to the Editor Errata Advertisement 2013 IMPACT FACTOR 5.177 Cell Death & Disease is an online-only, open access journal seeking to promote diverse and integrated areas of experimental and internal medicine with its specialities, including cancer, cancer metabolism, immunity and neuroscience. Explore the benefits of submitting your next research article: http://bit.ly/1t4BIFJ REVIEW B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? P J Hengeveld and M J Kersten Blood Cancer J 2015 5: e282; 10.1038/bcj.2015.3 Abstract | Full Text ORIGINAL ARTICLE Top PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival Z -Z Yang, D M Grote, S C Ziesmer, B Xiu, A J Novak and S M Ansell Blood Cancer J 2015 5: e281; 10.1038/bcj.2015.1 Abstract | Full Text LETTERS TO THE EDITOR Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy Z R Chalmers, S M Ali, R S Ohgami, P V Campregher, G M Frampton, R Yelensky, J A Elvin, N A Palma, R Erlich, J-A Vergilio, J Chmielecki, J S Ross, P J Stephens, R Hermann, V A Miller and C R Miles Blood Cancer J 2015 5: e278; 10.1038/bcj.2014.95 Full Text Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma’ P-Y Hsieh, C-J Liu and C-J Teng Blood Cancer J 2015 5: e283; 10.1038/bcj.2015.4 Full Text t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs T Narita, A Inagaki, T Kobayashi, Y Kuroda, T Fukushima, M Nezu, S Fuchida, H Sakai, N Sekiguchi, I Sugiura, Y Maeda, H Takamatsu, N Tsukamoto, D Maruyama, Y Kubota, M Kojima, K Sunami, T Ono, M Ri, K Tobinai and S Iida Blood Cancer J 2015 5: e285; 10.1038/bcj.2015.6 Full Text Absence of natural intracellular retinoids in mouse bone marrow cells and implications for PML-RARA transformation H Niu, J Chacko, G Hadwiger and J S Welch Blood Cancer J 2015 5: e284; 10.1038/bcj.2015.2 Full Text ERRATA Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study A J Greenberg, S Philip, A Paner, S Velinova, A Badros, R Catchatourian, R Ketterling, R A Kyle, S Kumar, C M Vachon and S V Rajkumar Blood Cancer J 2015 5: e279; 10.1038/bcj.2015.8 Full Text Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome M M Patnaik, E A Wassie, E Padron, F Onida, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R P Ketterling, R Komrokji, A Tefferi and E Solary Blood Cancer J 2015 5: e280; 10.1038/bcj.2015.9 Full Text Advertisement 2013 IMPACT FACTOR 2.884 Blood Cancer Journal is an online-only, open access journal seeking to publish articles of the highest quality concerning hematologic malignancies and related disorders. Explore the benefits of submitting your next research article: http://bit.ly/1FpVSOx